Image credit: Alyson Martin

NIDA Welcomes Proposals From New Cannabis Suppliers

Today, seven entities meet the basic criteria to compete for a contract to supply the National Institute on Drug Abuse with research-grade cannabis, and it could be worth up to $25 million.

Research
New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.